DXS International (STU:7EE) Total Equity: €0.42 Mil (As of Apr. 2025)


STU:7EE DXS International PLC STU:7EE
39 GF Score
Price €0.01
GF Value €0.02
! 2 Warning Signs
View Full Analysis

What is DXS International Total Equity?

DXS International STU:7EE 39 Total Equity is €0.42 Mil as of Apr. 2025. GuruFocus rates STU:7EE with a GF Score™ of 39/100 and a GF Value™ of €0.02. The stock has 2 warning signs investors should review.

DXS International's total equity for the quarter that ended in Apr. 2025 was €0.42 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

DXS International Total Equity Historical Data

* Premium members only.

The historical data trend for DXS International's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DXS International Total Equity Chart

DXS International Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.80 5.23 5.21 0.52 0.42

DXS International Semi-Annual Data
Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 4.80 5.23 5.21 0.52 0.42
STU:7EE
39GF Score
DXS International PLC STU:7EE
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DXS International Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

DXS International's Total Equity for the fiscal year that ended in Apr. 2025 is calculated as

Total Equity=Total Assets(Q: Apr. 2025 )-Total Liabilities(Q: Apr. 2025 )
=2.773-2.35
=0.42

DXS International's Total Equity for the quarter that ended in Apr. 2025 is calculated as

Total Equity=Total Assets(Q: Apr. 2025 )-Total Liabilities(Q: Apr. 2025 )
=2.773-2.35
=0.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of €0.42 Mil mean?
DXS International (STU:7EE) has a Total Equity of €0.42 Mil as of Apr. 2025. The total amount of equity as record on a company's balance sheet. View historical data for DXS International and its competitors.
Is DXS International's Total Equity too high?
DXS International's current Total Equity is €0.42 Mil. Overall, DXS International has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does DXS International's Total Equity compare to VEEV and BTSG?
DXS International's Total Equity of €0.42 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Healthcare Providers & Services company?
A good Total Equity depends on the Healthcare Providers & Services industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for DXS International and its competitors. DXS International's current Total Equity is €0.42 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DXS International stock overvalued right now?
DXS International (STU:7EE) has a current Total Equity of €0.42 Mil. The stock's GF Value™ is €0.02, compared to a current price of €0.01 — trading 45% below its estimated fair value. The current Total Equity is €0.42 Mil. DXS International's overall GF Score™ is 39/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For DXS International (STU:7EE), the current Total Equity is €0.42 Mil as of Apr. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DXS International (STU:7EE) Overvalued in 2026?

Based on GuruFocus' analysis, DXS International stock appears to be undervalued. The current stock price of €0.01 is trading 45% below its estimated GF Value™ of €0.02.

Key valuation signals for STU:7EE:

  • Total Equity: €0.42 Mil
  • GF Value™: €0.02 vs. price of €0.01 (45% below fair value)
  • GF Score™: 39/100 with 2 warning signs

No single metric tells the full story. See the STU:7EE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DXS International Business Description

Other Exchanges DXSP:UK
Address 119 Saint Mary’s Road, Market Harborough, London, Leicestershire, GBR, LE16 7DT
DXS International PLC is engaged in the development and distribution of clinical decision support systems for General Practitioners, nurses, and retail pharmacies in the United Kingdom and South Africa. Its commercial activities include licensing DXS products to various ICBs, offering e-detailing opportunities to the pharmaceutical industry and the UK primary care sector, and licensing its technology to healthcare publishers. The company's products include BestPathway and Point-of-Care ExpertCare.
39GF Score

Get the complete analysis for STU:7EE

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.01
Price
€0.02
GF Value